1
|
Mackie CJ, Lu W, Liang J, Kostko O, Bandyopadhyay B, Gupta I, Ahmed M, Head-Gordon M. Magic Numbers and Stabilities of Photoionized Water Clusters: Computational and Experimental Characterization of the Nanosolvated Hydronium Ion. J Phys Chem A 2023. [PMID: 37441795 DOI: 10.1021/acs.jpca.3c02230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/15/2023]
Abstract
The stability and distributions of small water clusters generated in a supersonic beam expansion are interrogated by tunable vacuum ultraviolet (VUV) radiation generated at a synchrotron. Time-of-flight mass spectrometry reveals enhanced population of various protonated water clusters (H+(H2O)n) based upon ionization energy and photoionization distance from source, suggesting there are "magic" numbers below the traditional n = 21 that predominates in the literature. These intensity distributions suggest that VUV threshold photoionization (11.0-11.5 eV) of neutral water clusters close to the nozzle exit leads to a different nonequilibrium state compared to a skimmed molecular beam. This results in the appearance of a new magic number at 14. Metadynamics conformer searches coupled with modern density functional calculations are used to identify the global minimum energy structures of protonated water clusters between n = 2 and 21, as well as the manifold of low-lying metastable minima. New lowest energy structures are reported for the cases of n = 5, 6, 11, 12, 16, and 18, and special stability is identified by several measures. These theoretical results are in agreement with the experiments performed in this work in that n = 14 is shown to exhibit additional stability, based on the computed second-order stabilization energy relative to most cluster sizes, though not to the extent of the well-known n = 21 cluster. Other cluster sizes that show some additional energetic stability are n = 7, 9, 12, 17, and 19. To gain insight into the balance between ion-water and water-water interactions as a function of the cluster size, an analysis of the effective two-body interactions (which sum exactly to the total interaction energy) was performed. This analysis reveals a crossover as a function of cluster size between a water-hydronium-dominated regime for small clusters and a water-water-dominated regime for larger clusters around n = 17.
Collapse
Affiliation(s)
- Cameron J Mackie
- Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States
- Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States
| | - Wenchao Lu
- Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States
| | - Jiashu Liang
- Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States
| | - Oleg Kostko
- Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States
| | - Biswajit Bandyopadhyay
- Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States
| | - Ishan Gupta
- Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States
| | - Musahid Ahmed
- Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States
| | - Martin Head-Gordon
- Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States
- Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States
| |
Collapse
|
2
|
Lorenz N, Gupta I, Palberg T. Microstructural diversity, nucleation paths, and phase behavior in binary mixtures of charged colloidal spheres. J Chem Phys 2023; 158:114902. [PMID: 36948792 DOI: 10.1063/5.0140949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/17/2023] Open
Abstract
We study low-salt, binary aqueous suspensions of charged colloidal spheres of size ratio Γ = 0.57, number densities below the eutectic number density nE, and number fractions of p = 1.00-0.40. The typical phase obtained by solidification from a homogeneous shear-melt is a substitutional alloy with a body centered cubic structure. In strictly gas-tight vials, the polycrystalline solid is stable against melting and further phase transformation for extended times. For comparison, we also prepare the same samples by slow, mechanically undisturbed deionization in commercial slit cells. These cells feature a complex but well reproducible sequence of global and local gradients in salt concentration, number density, and composition as induced by successive deionization, phoretic transport, and differential settling of the components, respectively. Moreover, they provide an extended bottom surface suitable for heterogeneous nucleation of the β-phase. We give a detailed qualitative characterization of the crystallization processes using imaging and optical microscopy. By contrast to the bulk samples, the initial alloy formation is not volume-filling, and we now observe also α- and β-phases with low solubility of the odd component. In addition to the initial homogeneous nucleation route, the interplay of gradients opens various further crystallization and transformation pathways leading to a great diversity of microstructures. Upon a subsequent increase in salt concentration, the crystals melt again. Wall-based, pebble-shaped β-phase crystals and facetted α-crystals melt last. Our observations suggest that the substitutional alloys formed in bulk experiments by homogeneous nucleation and subsequent growth are mechanically stable in the absence of solid-fluid interfaces but thermodynamically metastable.
Collapse
Affiliation(s)
- Nina Lorenz
- Institute of Physics, Johannes Gutenberg University, 55122 Mainz, Germany
| | - Ishan Gupta
- Graz University of Technology, Institute of Applied Mechanics, Graz, Austria
| | - Thomas Palberg
- Institute of Physics, Johannes Gutenberg University, 55122 Mainz, Germany
| |
Collapse
|
3
|
Nagal S, Raja A, Gupta I, Adin SN, Panda BP. Screening and Development of β-Carotene Enriched Phaffia rhodozyma Cell by Culture Media Engineering. Microbiology (Reading) 2023. [DOI: 10.1134/s002626172210068x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/03/2023] Open
|
4
|
Gupta S, Das N, Amaranath-Bj J, Gupta I, Tripathi A, Singh D. Knowledge and Awareness about Systemic Effects of Periodontal Disease among Medical, Dental and Alternate Medical Practitioners and Their Referral Practice to Periodontists. Mymensingh Med J 2022; 31:1153-1161. [PMID: 36189566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
In the past few decades, many medical professionals and dentists have paid close notice to their own fields, specializing in medicine pertaining to body and oral cavity respectively. Currently, this void is rapidly closing between all medical specialties, in presence of significant findings that supports association between periodontal disease and systemic conditions. Till now, some practitioners are not aware about the specialties of dentistry that results in improper referral practices. There are few studies on referral practice pertaining to periodontist, not with standing the fact that clear and effective communication between all health practitioners is essential for good practice. A cross-sectional study was carried out to assess the knowledge and awareness about systemic effects of periodontal disease among medical, dental and alternate medical practitioners and their referral practice to periodontist in Kanpur city. This cross-sectional study was carried out using self-reported questionnaire, distributed to 560 practitioners of various medical fields from January 2020 to August 2021. A total of 206(36.8%) Medical, 194(34.6%) Dentists and 160(28.6%) alternative practitioners participated in study. More than half participants agreed about relationship between periodontal diseases and Diabetes Mellitus, Cardio-VascularDisease and Adverse Pregnancy Outcomes. Among all 31.3% showed good knowledge level while 2.7% showed perfect level of practitioner's referral practice to periodontist. Dentists had statistically higher level of awareness compared to physicians. Referral practice to periodontist was deficit by medical and alternate medical practitioners despite of fact; they have good knowledge of relationship between periodontal disease and systemic health. Hence, interdisciplinary dental and medical training of practitioners is recommended.
Collapse
Affiliation(s)
- S Gupta
- Dr Shruti Gupta, Associate Professor, Department of Periodontology, Rama Dental College Hospital & Research Centre, Kanpur, Uttar Pradesh (UP), India; E-mail:
| | | | | | | | | | | |
Collapse
|
5
|
Mahajan S, Nambirajan A, Gupta I, Gupta N, Gupta P, Jain D. Malignant pleural effusion cell blocks are reliable resources for PD-L1 analysis in advanced lung adenocarcinomas: a concordance study with matched histologic samples. J Am Soc Cytopathol 2022; 11:253-263. [PMID: 35589508 DOI: 10.1016/j.jasc.2022.04.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Revised: 04/12/2022] [Accepted: 04/14/2022] [Indexed: 06/15/2023]
Abstract
INTRODUCTION In lung cancer patients presenting with malignant pleural effusion (MPE), cytology might represent the only source of tumor tissue for diagnosis and predictive biomarker testing. Programmed death ligand 1 (PD-L1) expression in tumor cells is a predictive biomarker for immunotherapy in non-small cell lung carcinomas and is tested using immunohistochemistry. However, knowledge of the validity of PD-L1 testing on MPE samples is limited. We evaluated the feasibility of immunocytochemistry (ICC) for PD-L1 in MPE cell blocks (CBs) and assessed the concordance in expression with patient-matched histologic samples. MATERIALS AND METHODS ICC for PD-L1 was performed on formalin-fixed paraffin-embedded CBs of MPE and patient-matched histologic samples, if available, using the automated Ventana PD-L1 SP263 assay. The tumor proportion score (TPS), based on partial or complete membranous tumor cell staining, was categorized as negative (<1%), low (≥1% to <50%), and high (≥50%). In CBs with any degree of PD-L1 expression, ICC for CD163 highlighting macrophages was performed to exclude nonspecific PD-L1 expression in macrophages. The CB PD-L1 TPS was compared with the TPS obtained from the patient-matched histologic samples. RESULTS Of 43 MPE CBs available, 25 were positive for PD-L1 (25 of 42; 59%), and 1 sample was inadequate. Of the 11 patient-matched histologic samples tested, the PD-L1 TPS categories were concordant for 10 of the 11 (91% concordance) cases. CONCLUSIONS PD-L1 expression in MPE CBs showed good concordance with expression in histologic samples and is feasible as a source for PD-L1 testing. The concurrent use of CD163 immunostains will aid in the manual assessment of PD-L1 TPS.
Collapse
Affiliation(s)
- Swati Mahajan
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - Aruna Nambirajan
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - Ishan Gupta
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - Nalini Gupta
- Department of Cytology and Gynecologic Pathology, Post Graduate Institute of Medical Sciences and Research, Chandigarh, India
| | - Parikshaa Gupta
- Department of Cytology and Gynecologic Pathology, Post Graduate Institute of Medical Sciences and Research, Chandigarh, India
| | - Deepali Jain
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
| |
Collapse
|
6
|
Malhotra S, Mani K, Lodha R, Bakhshi S, Mathur VP, Gupta P, Kedia S, Sankar MJ, Kumar P, Kumar A, H V, Ahuja V, Sinha S, Guleria R, Dua A, Ahmad S, Upadhyay AD, Sati HC, Mani K, Lokade AK, Devi KP, Johnson RM, Gowthaman K, Kumari M, Singh R, Kalra D, Swetambri, Vasudha, Sharma S, Singh A, Sharma V, Kanswal S, Sharma R, Giri T, Rajput S, Mehra G, Sharma A, Madan D, Singh M, Gupta A, Sharma S, Sachdeva S, Kumar M, Sachin, Singh AK, Gohar N, Kumar R, Kanojia N, Singhania J, Dubey R, Shukla S, G A, Sarkar S, Gupta I, Rai S, Tummala S, Reddy T, Vadodaria V, Sharma A, Gupta A, Vats M, Deori TJ, Jaiswal A, Pandit S. COVID-19 infection, and reinfection, and vaccine effectiveness against symptomatic infection among health care workers in the setting of omicron variant transmission in New Delhi, India. Lancet Reg Health Southeast Asia 2022; 3:100023. [PMID: 35769163 PMCID: PMC9167830 DOI: 10.1016/j.lansea.2022.100023] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Background Surge of SARS CoV-2 infections ascribed to omicron variant began in December 2021 in New Delhi. We determined the infection and reinfection density in a cohort of health care workers (HCWs) along with vaccine effectiveness (VE) against symptomatic infection within omicron transmission period (considered from December 01, 2021 to February 25, 2022. Methods This is an observational study from the All India Institute of Medical Sciences, New Delhi. Data were collected telephonically. Person-time at risk was counted from November 30, 2021 till date of infection/ reinfection, or date of interview. Comparison of clinical features and severity was done with previous pandemic periods. VE was estimated using test-negative case-control design [matched pairs (for age and sex)]. Vaccination status was compared and adjusted odds ratios (OR) were computed by conditional logistic regression. VE was estimated as (1-adjusted OR)X100-. Findings 11474 HCWs participated in this study. The mean age was 36⋅2 (±10⋅7) years. Complete vaccination with two doses were reported by 9522 (83%) HCWs [8394 (88%) Covaxin and 1072 Covishield (11%)]. The incidence density of all infections and reinfection during the omicron transmission period was 34⋅8 [95% Confidence Interval (CI): 33⋅5-36⋅2] and 45⋅6 [95% CI: 42⋅9-48⋅5] per 10000 person days respectively. The infection was milder as compared to previous periods. VE was 52⋅5% (95% CI: 3⋅9-76⋅5, p = 0⋅036) for those who were tested within 14-60 days of receiving second dose and beyond this period (61-180 days), modest effect was observed. Interpretation Almost one-fifth of HCWs were infected with SARS CoV-2 during omicron transmission period, with predominant mild spectrum of COVID-19 disease. Waning effects of vaccine protection were noted with increase in time intervals since vaccination. Funding None.
Collapse
Affiliation(s)
- Sumit Malhotra
- Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Kalaivani Mani
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
| | - Rakesh Lodha
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Sameer Bakhshi
- Department of Medical Oncology, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Vijay Prakash Mathur
- Division of Pedodontics and Preventive Dentistry, Centre for Dental Education and Research, All India Institute of Medical Sciences, New Delhi, India
| | - Pooja Gupta
- Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India
| | - Saurabh Kedia
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Mari Jeeva Sankar
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Parmeshwar Kumar
- Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India
| | - Arvind Kumar
- Department of Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Vikas H
- Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India
| | - Vineet Ahuja
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Subrata Sinha
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
| | | | - Aman Dua
- Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Shafi Ahmad
- Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Ashish Datt Upadhyay
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
| | - Hem Chandra Sati
- Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
| | - Kiruba Mani
- Dr. Rajendra Prasad Centre For Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
| | - Amol Kumar Lokade
- Centre For Dental Education And Research, All India Institute of Medical Sciences, New Delhi, India
| | - K Pavithra Devi
- Centre For Dental Education And Research, All India Institute of Medical Sciences, New Delhi, India
| | - Riya Marie Johnson
- Centre For Dental Education And Research, All India Institute of Medical Sciences, New Delhi, India
| | - Keerthana Gowthaman
- Centre For Dental Education And Research, All India Institute of Medical Sciences, New Delhi, India
| | - Mamta Kumari
- Department of Medical Oncology, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Ritika Singh
- Department of Medical Oncology, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Devanshi Kalra
- Department of Medical Oncology, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Swetambri
- Department of Medical Oncology, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Vasudha
- Department of Medical Oncology, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Shubhangi Sharma
- Department of Medical Oncology, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
| | - Amit Singh
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India
| | - Vikas Sharma
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India
| | - Sunita Kanswal
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India
| | - Rahul Sharma
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India
| | - Tanika Giri
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India
| | - Simple Rajput
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India
| | - Geeta Mehra
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India
| | - Amit Sharma
- Centralized Core Research Facility, All India Institute of Medical Sciences, New Delhi, India
| | - Divya Madan
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Mukesh Singh
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Anvita Gupta
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Shilpi Sharma
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Surbhi Sachdeva
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Mayank Kumar
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Sachin
- Department of Gastroenterology & Human Nutrition, All India Institute of Medical Sciences, New Delhi, India
| | - Ajay Kumar Singh
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Naveen Gohar
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Ramu Kumar
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Nitin Kanojia
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Jyoti Singhania
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Ritu Dubey
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India
| | - Sakshi Shukla
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
| | - Abishek G
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India
| | - Swarnabha Sarkar
- Department of Physiology, All India Institute of Medical Sciences, New Delhi, India
| | - Ishan Gupta
- All India Institute of Medical Sciences, New Delhi, India
| | - Sabin Rai
- All India Institute of Medical Sciences, New Delhi, India
| | | | - Thrisha Reddy
- All India Institute of Medical Sciences, New Delhi, India
| | | | - Ajay Sharma
- Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Amit Gupta
- Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Manish Vats
- Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Trideep Jyoti Deori
- Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Abhishek Jaiswal
- Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India
| | - Sabitri Pandit
- Medical Device Monitoring Center, Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
7
|
Gupta I, Thorrowgood M, Ashton K, Chapple V, Liu Y. P-203 Searching for the optimal timing of intracytoplasmic sperm injection post oocyte retrieval: a systematic review and meta-analysis. Hum Reprod 2022. [DOI: 10.1093/humrep/deac107.196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Study question
What is the optimal time post oocyte retrieval (POR) to undertake intracytoplasmic sperm injection (ICSI) in order to maximise subsequent pregnancy and live birth outcomes?
Summary answer
Delaying ICSI for 5 hours or more POR may compromise subsequent clinical pregnancy and live birth rates.
What is known already
It is often challenging to perform ICSI at a set timing POR, especially in ART clinics with a heavy workload. However, the degree of flexibility in ICSI timing remains unclear in the literature. Some articles have reported detrimental impacts by delaying ICSI on the subsequent treatment outcomes (Pujol et al 2018), while others reported no evidence of adverse effects caused by different ICSI timings (Vandenberghe et al 2021). Therefore, we aimed to explore a “safety time window” for ICSI procedures to enable flexibility in workflow arrangement without compromising pregnancy outcomes.
Study design, size, duration
A systematic review and meta-analysis were performed according to PRISMA guidelines, with protocol registered with PROSPERO (ID: CRD42022296838). The studies were searched for in PubMed, MEDLINE, EMBASE and the Cochrane Library on 16 December 2021, using (“subfertile” OR “sub-fertile” OR “infert*” OR “fertility treatment” OR “women” OR “female” OR “couple”) AND (“ICSI” OR “intracytoplasmic sperm injection” OR “intra-cytoplasmic sperm injection”) AND (“timing” OR “time interval”) AND (“pregnancy” OR “fertili*” OR “birth”) NOT (Review [Publication Type]).
Participants/materials, setting, methods
Two independent reviewers systematically evaluated each study on patient, intervention, comparison, and outcome (PICO). The Newcastle-Ottawa scale was used for risk of bias assessment in non-randomised trials and observational studies. Further screening was performed separately by the two independent reviewers, with differences mediated by the third reviewer. Data extraction was performed according to Cochrane methods. Clinical pregnancy or live birth data were synthesised from eligible studies depending on availability of raw data in corresponding subgroups.
Main results and the role of chance
A total of 605 records were hit in the search. After initial exclusion according to PICO, 30 articles were included for further screening for eligibility. For meta-analysis, 4 retrospective cohort studies were eventually included for clinical pregnancy rate assessment while 2 for live birth rate analysis. Due to different groupings in ICSI timing amongst these studies, a series of comparisons on ICSI timings with a cut-off at an hourly increment were set up to pool data from the 4 included studies where applicable. Clinical pregnancy rates were comparable when ICSI was performed (a) 2+ hours (n = 6448, Relative Risk or RR = 1.031, 95% CI 0.964-1.102) in reference to < 2 hours POR (n = 2336), (b) 3+ hours (n = 5101, RR = 1.005, 95% CI 0.945-1.069) in reference to < 3 hours POR (n = 3465), and (c) 4+ hours (n = 3192, RR = 1.017, 95% CI 0.956-1.082) in reference to < 4 hours POR (n = 5374). However, clinical pregnancy rates were significantly compromised when ICSI was performed at 5+ hours (n = 2335, RR = 1.103, 95% CI 1.036-1.175) in reference to < 5 hours POR (n = 7169). Similarly, live birth rate was also significantly reduced when ICSI was performed 5+ hours (n = 2335, RR = 1.155, 95% CI 1.070-1.246) in reference to < 5 hours POR (n = 7169).
Limitations, reasons for caution
All studies included for meta-analysis were retrospective with heterogeneity. There were various groupings amongst studies due to the wide range of ICSI timings POR, which limits data pooling and subsequent comparisons. A future well designed randomised controlled trial is warranted for further analysis based on better quality evidence.
Wider implications of the findings
Our results indicate 5 hours POR should be considered the maximum time limit to perform ICSI. This finding, supported by statistics with improved power through meta-analysis, offers valuable guidance to busy clinics. This information could both improve pregnancy outcomes and allow better workflow arrangements without compromising them.
Trial registration number
not applicable
Collapse
Affiliation(s)
- I Gupta
- Bond university, School of Health Sciences and Medicine , Robina, Australia
| | - M Thorrowgood
- Bond university, School of Health Sciences and Medicine , Robina, Australia
| | - K Ashton
- Bond university, School of Health Sciences and Medicine , Robina, Australia
| | - V Chapple
- Fertility North , Medical, Joondalup, Australia
| | - Y Liu
- Fertility North, Laboratory , Joondalup, Australia
| |
Collapse
|
8
|
Hughes G, Li D, Kerrigan R, Gupta I, Wilkinson S. O03 ST97 Staphylococcus aureus and oxacillin resistance: an emerging challenge for microbiologists? JAC Antimicrob Resist 2022. [PMCID: PMC9156019 DOI: 10.1093/jacamr/dlac052.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Background The presence of cefoxitin and oxacillin resistance in Staphylococcus aureus isolates is suggestive of methicillin resistance (MRSA) with molecular detection of the mecA or mecC genes providing confirmation. The UK SMI and EUCAST guidelines for MRSA detection describe a subset of strains that exhibit reduced susceptibility to oxacillin and cefoxitin, though negative for mecA and mecC genes—frequently named borderline oxacillin-resistant S. aureus (BORSA). Local data noted a number of S. aureus isolates that matched the above phenotype leading to laboratory, clinical and epidemiological questions. Methods Routine samples were collected between August 2020 and April 2021 at West Midlands Health Security Agency Laboratory, Birmingham. If provisional results suggested an MRSA isolate, the following confirmatory tests were undertaken. Locally, clinical samples underwent susceptibility testing with cefoxitin disc diffusion and oxacillin gradient diffusion (MRSA screens) or Vitek 2 (non-MRSA screens). Isolates with discrepant results [susceptible to cefoxitin; resistant to oxacillin (MIC >2 mg/L) or vice versa] were sent to the reference laboratory at Colindale, UK for further testing, which included mecA or mecC gene detection by PCR and serotyping with Illumina sequencing for all isolates. Results In total, 53 isolates were sent to the reference lab of which 22 were confirmed to have an ST97 serotype. All 53 were negative by PCR for mecA and mecC genes. For the 22 isolates of ST97, local oxacillin MIC values ranged from 2 to 6 mg/L. Cefoxitin susceptibility was confirmed locally in all isolates. The 22 isolates were from 15 patients; wound swabs (n = 18); blood culture (n = 1), sputum (n = 1) and MRSA screen (n = 2). Median patient age was 48 years (IQR 38–59) with 5 being female and 10 male. A history of injecting drug use was documented in 53% (8/15). Conclusions BORSA remains a problem from a laboratory, clinical and infection control perspective. This work raises two important questions: what is the most appropriate local laboratory testing pathway and what is the clinical relevance of these isolates (i.e. can flucloxacillin be relied upon in treatment)? The ST97 serotype appears to be associated with skin and soft tissue infection and may be linked to people who inject drugs.
Collapse
Affiliation(s)
- G Hughes
- UKHSA lab , Birmingham, B9 5SS, UK
| | - D Li
- UKHSA lab , Birmingham, B9 5SS, UK
| | | | - I Gupta
- UKHSA lab , Birmingham, B9 5SS, UK
| | | |
Collapse
|
9
|
Gupta I, Ramteke P, Narwal A, Sharma MC, Bakhshi S, Mallick S. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma. Am J Dermatopathol 2022; 44:376-379. [PMID: 35234192 DOI: 10.1097/dad.0000000000002168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
ABSTRACT Primary cutaneous anaplastic large-cell lymphoma (C-ALCL) is a cutaneous CD30-positive lymphoproliferative disorder. The patients usually present with single or multiple cutaneous nodules or papules and about 10% cases present with extracutaneous manifestations, which are predominantly in the form of regional lymph nodal involvement. Visceral involvement especially pulmonary or hepatic involvement in C-ALCL is only rarely described in the scientific literature. Approximately 20%-42% cases show spontaneous regression, about 50% cases may recur; however, C-ALCL generally carries a good prognosis. We present a rare case of primary C-ALCL in a 66-year-old man with regional lymph nodal and hepatic involvement. Differential diagnostic entities are discussed in this report with the review of the literature.
Collapse
Affiliation(s)
| | | | | | | | - Sameer Bakhshi
- Medical Oncology, Dr B. R. A. Institute Rotary Cancer Hospital (Dr. B. R. A. IRCH), All India Institute of Medical Sciences (AIIMS), New Delhi, India
| | | |
Collapse
|
10
|
Arora U, Priyadarshi M, Katiyar V, Soneja M, Garg P, Gupta I, Bharadiya V, Berry P, Ghosh T, Patel L, Sarda R, Garg S, Agarwal S, Arora V, Ramprasad A, Kumar A, Garg RK, Kodan P, Nischal N, Singh G, Jorwal P, Kumar A, Baitha U, Meena VP, Ray A, Sethi P, Xess I, Vikram N, Sinha S, Biswas A, Thakar A, Bhatnagar S, Trikha A, Wig N. Risk factors for Coronavirus disease-associated mucormycosis. J Infect 2022; 84:383-390. [PMID: 34974056 PMCID: PMC8717704 DOI: 10.1016/j.jinf.2021.12.039] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2021] [Revised: 12/20/2021] [Accepted: 12/27/2021] [Indexed: 01/09/2023]
Abstract
BACKGROUND The epidemiology of the Coronavirus-disease associated mucormycosis (CAM) syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden of cases and help develop preventive strategies. METHODS We performed a case-control study comparing cases diagnosed with CAM and taking controls as recovered COVID 19 patients who did not develop mucormycosis. Information on comorbidities, glycemic control, and practices related to COVID-19 prevention and treatment was recorded. Multivariate regression analysis was used to identify independent predictors. RESULTS A total of 352 patients (152 cases and 200 controls) diagnosed with COVID-19 during April-May 2021 were included. In the CAM group, symptoms of mucormycosis began a mean of 18.9 (SD 9.1) days after onset of COVID-19, and predominantly rhino-sinus and orbital involvement was present. All, but one, CAM cases had conventional risk factors of diabetes and steroid use. On multivariable regression, increased odds of CAM were associated with the presence of diabetes (adjusted OR 3.5, 95% CI 1.1-11), use of systemic steroids (aOR 7.7, 95% CI 2.4-24.7), prolonged use of cloth and surgical masks (vs. no mask, aOR 6.9, 95%CI 1.5-33.1), and repeated nasopharyngeal swab testing during the COVID-19 illness (aOR 1.6, 95% CI 1.2-2.2). Zinc therapy was found to be protective (aOR 0.05, 95%CI 0.01-0.19). Notably, the requirement of oxygen supplementation or hospitalization did not affect the risk of CAM. CONCLUSION Judicious use of steroids and stringent glycemic control are vital to preventing mucormycosis. Use of clean masks, preference for N95 masks if available, and minimizing swab testing after the diagnosis of COVID-19 may further reduce the incidence of CAM.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | - Shreya Garg
- Department of Otolaryngology & Head-Neck Surgery, AIIMS, Delhi, India
| | | | - Veronica Arora
- Department of Medical Genetics, Sir Ganga Ram Hospital, Delhi, India
| | | | - Amit Kumar
- Department of Medicine, AIIMS, Delhi, India
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - Alok Thakar
- Department of Otolaryngology & Head-Neck Surgery, AIIMS, Delhi, India
| | - Sushma Bhatnagar
- Department of Onco-anaesthesia and Palliative Medicine, AIIMS, Delhi, India
| | - Anjan Trikha
- Department of Anaesthesiology, Pain Medicine and Critical Care, AIIMS, Delhi, India
| | - Naveet Wig
- Department of Medicine, AIIMS, Delhi, India,Corresponding author
| |
Collapse
|
11
|
Gupta I, Mahendran S, Davis J, Davis A, Orchard J, Orchard J. A Comparison of QT Interval Correction Methods on Electrocardiograms (ECG) of Athletes and Young People: A Systematic Review. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
12
|
Mahendran S, Gupta I, Davis J, Davis A, Orchard J, Orchard J. Comparison of Methods for Correcting QT Interval in Athletes and Young People: A Systematic Literature Review. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.04.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
13
|
Kantroo V, Kanwar MS, Goyal P, Rosha D, Modi N, Bansal A, Ansari AP, Wangnoo SK, Sobti S, Kansal S, Chawla R, Jasuja S, Gupta I. Mortality and Clinical Outcomes among Patients with COVID-19 and Diabetes. Med Sci (Basel) 2021; 9:medsci9040065. [PMID: 34842758 PMCID: PMC8628982 DOI: 10.3390/medsci9040065] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2021] [Revised: 10/19/2021] [Accepted: 10/22/2021] [Indexed: 12/11/2022] Open
Abstract
Background Diabetes mellitus (DM) is a decisive risk factor for severe illness in coronavirus disease 2019 (COVID-19). India is home to a large number of people with DM, and many of them were infected with COVID-19. It is critical to understand the impact of DM on mortality and other clinical outcomes of COVID-19 infection from this region. Aims The primary objective of our study was to analyze the mortality rate in people with DM infected with COVID-19. The secondary objectives were to assess the effect of various comorbidities on mortality and study the impact of DM on other clinical outcomes. Methods This is a retrospective study of COVID-19 infected patients admitted to a tertiary care hospital in north India in the early phase of the pandemic. Results Of the 1211 cases admitted, 19 were excluded because of incomplete data, and 1192 cases were finally considered for analysis. DM constituted 26.8% of total patients. The overall mortality rate was 6.1%, and the rate was 10.7% in the presence of diabetes (p < 0.01, OR 2.55). In univariate analysis, increased age, chronic kidney disease (CKD), coronary artery disease (CAD), stroke, and cancer were associated with mortality. On multiple logistic regression, the independent predictors of mortality were CAD, CKD, and cancer. Breathlessness and low SpO2 at presentation, extensive involvement in CXR, and elevated ANC/ALC ratio were also significantly associated with mortality. Conclusions The presence of comorbidities such as DM, hypertension, CAD, CKD, and cancer strongly predict the risk of mortality in COVID-19 infection. Early triaging and aggressive therapy of patients with these comorbidities can optimize clinical outcomes.
Collapse
Affiliation(s)
- Viny Kantroo
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
- Correspondence:
| | - Manjit S. Kanwar
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Piyush Goyal
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Deepak Rosha
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Nikhil Modi
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Avdhesh Bansal
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Athar Parvez Ansari
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Subhash Kumar Wangnoo
- Department of Apollo Centre of Diabetes and Endocrinology, Indraprastha Apollo Hospitals, New Delhi 110076, India;
| | - Sanjay Sobti
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Sudha Kansal
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Rajesh Chawla
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| | - Sanjiv Jasuja
- Department of Nephrology and Kidney Transplant, Indraprastha Apollo Hospitals, New Delhi 110076, India;
| | - Ishan Gupta
- Department of Respiratory, Critical Care and Sleep Medicine, Indraprastha Apollo Hospitals, New Delhi 110076, India; (M.S.K.); (P.G.); (D.R.); (N.M.); (A.B.); (A.P.A.); (S.S.); (S.K.); (R.C.); (I.G.)
| |
Collapse
|
14
|
Goel H, Rahul E, Gupta I, Chopra A, Ranjan A, Gupta AK, Meena JP, Viswanathan GK, Bakhshi S, Misra A, Hussain S, Kumar R, Singh A, Rath GK, Sharma A, Mittan S, Tanwar P. Molecular and genomic landscapes in secondary & therapy related acute myeloid leukemia. Am J Blood Res 2021; 11:472-497. [PMID: 34824881 PMCID: PMC8610791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/03/2021] [Accepted: 09/04/2021] [Indexed: 06/13/2023]
Abstract
Acute myeloid leukemia (AML) is a complex, aggressive myeloid neoplasm characterized by frequent somatic mutations that influence different functional categories' genes, resulting in maturational arrest and clonal expansion. AML can arise de novo (dn-AML) or can be secondary AML (s-AML) refers to a leukemic process which may arise from an antecedent hematologic disorder (AHD-AML), mostly from a myelodysplastic syndrome (MDS) or myeloproliferative neoplasm (MPN) or can be the result of an antecedent cytotoxic chemotherapy or radiation therapy (therapy-related AML, t-AML). Clinical and biological features in secondary and therapy-related AML are distinct from de novo AML. Secondary and therapy-related AML occurs mainly in the elderly population and responds worse to therapy with higher relapse rates due to resistance to cytotoxic chemotherapy. Over the last decade, advances in molecular genetics have disclosed the sub-clonal architecture of secondary and therapy-related AML. Recent investigations have revealed that cytogenetic abnormalities and underlying genetic aberrations (mutations) are likely to be significant factors dictating prognosis and critical impacts on treatment outcome. Secondary and therapy-related AML have a poorer outcome with adverse cytogenetic abnormalities and higher recurrences of unfavorable mutations compared to de novo AML. In this review, we present an overview of the clinical features of secondary and therapy-related AML and address the function of genetic mutations implicated in the pathogenesis of secondary leukemia. Detailed knowledge of the pathogenetic mechanisms gives an overview of new prognostic markers, including targetable mutations that will presumably lead to the designing and developing novel molecular targeted therapies for secondary and therapy-related AML. Despite significant advances in knowing the genetic aspect of secondary and therapy-related AML, its influence on the disease's pathophysiology, standard treatment prospects have not significantly evolved during the past three decades. Thus, we conclude this review by summarizing the modern and developing treatment strategies in secondary and therapy-related acute myeloid leukemia.
Collapse
Affiliation(s)
- Harsh Goel
- Laboratory Oncology Unit, Dr.B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical SciencesNew Delhi 110029, India
| | - Ekta Rahul
- Laboratory Oncology Unit, Dr.B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical SciencesNew Delhi 110029, India
| | - Ishan Gupta
- All India Institute of Medical SciencesNew Delhi 110029, India
| | - Anita Chopra
- Laboratory Oncology Unit, Dr.B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical SciencesNew Delhi 110029, India
| | - Amar Ranjan
- Laboratory Oncology Unit, Dr.B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical SciencesNew Delhi 110029, India
| | - Aditya Kumar Gupta
- Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences New DelhiNew Delhi 110029, India
| | - Jagdish Prasad Meena
- Division of Pediatric Oncology, Department of Pediatrics, All India Institute of Medical Sciences New DelhiNew Delhi 110029, India
| | - Ganesh Kumar Viswanathan
- Department of Hematology, All India Institute of Medical Sciences New DelhiNew Delhi 110029, India
| | - Sameer Bakhshi
- Department of Medical Oncology, Dr.B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical Sciences New DelhiNew Delhi 110029, India
| | - Aroonima Misra
- National Institute of Pathology, ICMRNew Delhi 110029, India
| | - Showket Hussain
- Division Of Molecular Oncology, National Institute of Cancer Prevention & Research I-7, Sector-39Noida 201301, India
| | - Ritesh Kumar
- Department of Radiation Oncology, Rudgers Cancer Institute of New JerseyNJ 07103, United States
| | - Archana Singh
- Department of Pathology, College of Medical Sciences, Rajasthan University of Health SciencesJaipur 302033, India
| | - GK Rath
- Department of Radiotherapy, Dr.B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical Sciences New DelhiNew Delhi 110029, India
| | - Ashok Sharma
- Department of Biochemistry, All India Institute of Medical Sciences New DelhiNew Delhi 110029, India
| | - Sandeep Mittan
- Department of Cardiology, Ichan School of Medicine, Mount Sinai Hospital1468 Madison Avenue, New York 10028, United States
| | - Pranay Tanwar
- Laboratory Oncology Unit, Dr.B.R.A. Institute Rotary Cancer Hospital All India Institute of Medical SciencesNew Delhi 110029, India
| |
Collapse
|
15
|
Sharma A, Gupta I, U V, Golamari R. E-Cigarettes and myocardial Infarction: a systemic review and meta-analysis. Eur J Prev Cardiol 2021. [DOI: 10.1093/eurjpc/zwab061.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
With widespread awareness about the harmful effects of traditional smoking, many people are considering the use of an e-cigarette. However, there are many studies which have shown e-cigarettes is not entirely harmless and it’s use has been implication in causing major adverse cardiovascular events.
Methodology
This systemic review strictly adhered to the PRISMA checklist. An electronic search was conducted comprehensively through five databases to find the relevant articles. The odds ratio (OR) was used for comparing groups. Meta-analysis was conducted using R statistical software version 3.4.3. A random-effect model was used.
Results
A total of 4 studies were included in the analysis incorporating data on 585,306 subjects. In these, 19,435 were e-cigarettes users, while 1693 used only traditional cigarette users, and 553,095 were non-e-cigarette users. A total of 7.0% of e-cigarette users suffered an MI in their lifetime, while only 6.5% of non-e-cigarette users have had MI. The OR of getting an MI in e-cigarettes users was 1.30 (95% CI = 1.23-1.38, p-value < 0.01) in comparison to non e-cigarette users. While it is 0.61 (95% CI = 0.40 – 0.93, p-value 0.02) when compared with traditional smoking.
Conclusion
Those using e-cigarettes have a higher odds of suffering from an MI in comparison to not using e-cigarettes. However, using e-cigarettes reduces the risk of MI by half in comparison to traditional smoking.
Abstract Figure. Forest plot
Collapse
Affiliation(s)
- A Sharma
- University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India
| | - I Gupta
- Dr. Rajendra Prasad Government Medical College, Tanda, Delhi, India
| | - V U
- Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi, India
| | - R Golamari
- Penn State Hershey Medical Center, Pennsylvania, United States of America
| |
Collapse
|
16
|
Gupta I, Bhalla AS, Mallick S, Mohan A, Jain D. An enigma of a rare pulmonary neoplasm in bronchial brushings. Cytopathology 2021; 32:534-537. [PMID: 33914365 DOI: 10.1111/cyt.12971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2020] [Revised: 01/13/2021] [Accepted: 02/27/2021] [Indexed: 11/27/2022]
Affiliation(s)
- Ishan Gupta
- Department of Pathology, AIIMS New Delhi, New Delhi, India
| | | | | | - Anant Mohan
- Department of Pulmonary Medicine and Sleep Disorders, AIIMS New Delhi, New Delhi, India
| | - Deepali Jain
- Department of Pathology, AIIMS New Delhi, New Delhi, India
| |
Collapse
|
17
|
Bamane SD, Bhojwani V, Balkunde PL, Bhattacharya M, Gupta I, Mohapatra AK, Shekhar A, Singh A. Smartphone-enabled field monitoring tool for rapid hexavalent chromium detection in water. Anal Bioanal Chem 2021; 413:3455-3469. [PMID: 33796931 DOI: 10.1007/s00216-021-03291-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 03/02/2021] [Accepted: 03/12/2021] [Indexed: 10/21/2022]
Abstract
Chromium contamination of soil and water is a serious environmental and public health concern as the hexavalent form of chromium [Cr(VI)] is readily soluble in water and is a confirmed carcinogen. There is an imminent need for a robust, low-cost, and simple analytical technique to facilitate in situ monitoring of Cr(VI) in water. Current quantitative methods of Cr(VI) detection are largely laboratory-based, time-consuming, expensive, and require training for implementation. In this contribution, a portable, easy-to-use, and compact measuring tool is presented that provides Cr(VI) concentration within 10 min of water sampling over a linear range of 0-3 mg L-1. This tool utilizes a relatively inexpensive camera-enabled smartphone with a custom-made test chamber attachment to seamlessly perform Cr(VI) measurements on water samples in the field. For analysis, an android-based software application was developed that directs the user to perform a simple series of steps following the diphenylcarbazide-based colorimetric method prescribed by the American Public Health Association. The tool was validated against a standard UV-visible spectrophotometer for a variety of synthetic and naturally contaminated water samples, with correlation factors greater than 0.993 (p < .001). The colorimetric method was also validated against a non-colorimetric Cr(VI) detection technique-ion chromatography-inductively coupled plasma mass spectrometry. Furthermore, Cr(VI) detection limits for the smartphone-enabled colorimetric method were found to be within 1.3-11.6 μg L-1, which were significantly better than reported for commercially available field test kits, and even surpassed the limits exhibited by a typical spectrophotometer (25-50 μg L-1). Finally, real-time mapping of source waters at a contaminated site was demonstrated by remote logging of Cr(VI) water quality data and corresponding GPS coordinates into a cloud server. This study highlights the potential role of smartphone-based monitoring tool in providing information to the affected community and enabling safe access to drinking water. An accurate, robust, simple-to-use, and economic method to measure hexavalent chromium in water within 10 min of sampling at site.
Collapse
Affiliation(s)
- Sushant D Bamane
- Foundation for Environmental Monitoring, Bangalore, Karnataka, 560001, India
| | - Vinod Bhojwani
- Department of Civil Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India.,Environmental Geochemistry Laboratory, Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India.,Inductis (India) Private Limited, Gurugram, Haryana, 122002, India
| | - Pradeep L Balkunde
- Foundation for Environmental Monitoring, Bangalore, Karnataka, 560001, India
| | - Mainak Bhattacharya
- Department of Civil Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India.,Environmental Geochemistry Laboratory, Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India
| | - Ishan Gupta
- Foundation for Environmental Monitoring, Bangalore, Karnataka, 560001, India
| | - Ashwini K Mohapatra
- Department of Civil Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India.,Environmental Geochemistry Laboratory, Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India
| | - Aditya Shekhar
- Department of Civil Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India.,Environmental Geochemistry Laboratory, Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India.,Civil Engineering Department, Motilal Nehru National Institute of Technology Allahabad, Prayagraj, Uttar Pradesh, 211004, India
| | - Abhas Singh
- Department of Civil Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India. .,Environmental Geochemistry Laboratory, Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, 208016, India.
| |
Collapse
|
18
|
Gupta I, Das N, Ranjan P, Sujatha R, Gupta R, Gupta N. A Preliminary Study on the Evaluation of In-vitro Inhibition Potential of Antimicrobial Efficacy of Raw and Commercial Honey on Escherichia coli: An Emerging Periodontal Pathogen. Mymensingh Med J 2021; 30:547-554. [PMID: 33830141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
Periodontitis, a multiple pathogen disease has the latest addition to the family i.e. Escherichia coli as a potential and emerging periodontal pathogen owing to its lipopolysaccharide more potent than Porphyromonas gingivalis, which makes it an emerging threat in periodontal disease. The role of antimicrobial agents in the management of periodontal diseases is of utmost importance. However, in the present scenario, antibiotic resistance is a public health concern now and there are very few options left for treatment. So, honey, a pioneer in traditional medicine was tried in the treatment against Escherichia coli to evaluate and compare the "in-vitro" antibacterial activity and efficacy of raw and commercial honey at different concentrations in comparison to tetracycline as a control on patient-isolated Escherichia coli and the American Type Culture Collection (ATCC) Escherichia coli 25922 strain from 5th Aug 2018 to 15th Feb 2019 at the Department of Microbiology, Rama Medical College, Kanpur (UP), India. In the in-vitro study different concentrations (100%, 75%, 50% and 25% v/v) of raw and commercial honey were studied and sensitivity tests were used to evaluate their antibacterial effect on patient-isolated Escherichia coli and the ATCC Escherichia coli 25922 strain. Minimum inhibitory concentration (MIC) and Minimum bactericidal concentration (MBC) were also determined for raw honey, and commercial honey in comparison to tetracycline. In case of raw honey, zone of inhibition was seen at 100%, 75% and 50% concentration, with maximum inhibition being 27±1.154mm and 23±0.666mm for patient-isolated Escherichia coli and ATCC Escherichia coli 25922 strain respectively at 100% concentration, whereas, the commercial honey was effective only at 100% and 75% concentration, with maximum inhibition zone of 13±1.054mm and 17±0.942mm at 100% concentration on patient-isolated Escherichia coli and ATCC Escherichia coli 25922 strain respectively. However, no effect was observed at 25% concentration for both raw and commercial honey. The MIC and MBC of raw and commercial honey were determined by the broth dilution method, where raw honey exhibited both MIC and MBC at 512 mg/ml whereas, and commercial honey exhibited MIC at 512mg/ml and MBC at 1024 mg/ml respectively. While comparing the zone of inhibition of raw and commercial honey, it was observed that the raw honey showed almost equivalent potency and efficacy as compared to a positive control tetracycline (2.5%). There was statistically significant difference (p≤0.01) in zone of inhibition of raw and commercial honey at 100% concentration on patient-isolated Escherichia coli and ATCC Escherichia coli 25922 strain. Antimicrobial activity of raw honey at 100% concentration was equivalent to that of tetracycline and was significantly better than commercial honey.
Collapse
Affiliation(s)
- I Gupta
- Professor Dr Ira Gupta, Professor, Department of Periodontology, Rama Dental College, Hospital & Research Centre (RDC, H&RC), Kanpur (UP)- 208024, India; E-mail:
| | | | | | | | | | | |
Collapse
|
19
|
Rai M, Ingle AP, Ingle P, Gupta I, Mobin M, Bonifaz A, Alves M. Recent advances on mycotic keratitis caused by dematiaceous hyphomycetes. J Appl Microbiol 2021; 131:1652-1667. [PMID: 33462841 DOI: 10.1111/jam.15008] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2020] [Revised: 12/31/2020] [Accepted: 01/14/2021] [Indexed: 02/06/2023]
Abstract
Dematiaceous hyphomycetes (DH) are darkly pigmented fungi ubiquitously found all over the world as plant pathogens and saprophytes, and many of the members of this group have emerged as opportunistic pathogens. These fungi are responsible for a wide variety of infections including mycotic keratitis, which is considered as one of the major causes of corneal blindness, particularly in tropical and subtropical countries with an annual global burden of about 1 000 000 patients. The infection is more common in workers working in an outdoor environment. Moreover, trauma is found to be the most important predisposing cause of mycotic keratitis. Considerable delay in diagnosis and scarcity of effective pharmacological drugs are the major factors responsible for increased morbidity and visual impairment. Considering the crucial role of DH in mycotic keratitis, in the present review, we have focused on major DH with special emphasis on their pathogenicity, diagnosis and treatment strategies.
Collapse
Affiliation(s)
- M Rai
- Department of Biotechnology, Sant Gadge Baba Amravati University, Amravati, Maharashtra, India
| | - A P Ingle
- Department of Biotechnology, Engineering School of Lorena, University of Sao Paulo, Lorena, SP, Brazil
| | - P Ingle
- Department of Biotechnology, Sant Gadge Baba Amravati University, Amravati, Maharashtra, India
| | - I Gupta
- Department of Biotechnology, Sant Gadge Baba Amravati University, Amravati, Maharashtra, India
| | - M Mobin
- Research Laboratory, University Center UNINOVAFAPI, Teresina, Brazil
| | - A Bonifaz
- Department of Mycology & Dermatology Service, General Hospital of Mexico, Mexico City, Mexico
| | - M Alves
- Department of Ophthalmology, University of Campinas, Campinas, SP, Brazil
| |
Collapse
|
20
|
Garrido-Godino AI, Gupta I, Gutiérrez-Santiago F, Martínez-Padilla AB, Alekseenko A, Steinmetz LM, Pérez-Ortín JE, Pelechano V, Navarro F. Rpb4 and Puf3 imprint and post-transcriptionally control the stability of a common set of mRNAs in yeast. RNA Biol 2020; 18:1206-1220. [PMID: 33094674 DOI: 10.1080/15476286.2020.1839229] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
Gene expression involving RNA polymerase II is regulated by the concerted interplay between mRNA synthesis and degradation, crosstalk in which mRNA decay machinery and transcription machinery respectively impact transcription and mRNA stability. Rpb4, and likely dimer Rpb4/7, seem the central components of the RNA pol II governing these processes. In this work we unravel the molecular mechanisms participated by Rpb4 that mediate the posttranscriptional events regulating mRNA imprinting and stability. By RIP-Seq, we analysed genome-wide the association of Rpb4 with mRNAs and demonstrated that it targeted a large population of more than 1400 transcripts. A group of these mRNAs was also the target of the RNA binding protein, Puf3. We demonstrated that Rpb4 and Puf3 physically, genetically, and functionally interact and also affect mRNA stability, and likely the imprinting, of a common group of mRNAs. Furthermore, the Rpb4 and Puf3 association with mRNAs depends on one another. We also demonstrated, for the first time, that Puf3 associates with chromatin in an Rpb4-dependent manner. Our data also suggest that Rpb4 could be a key element of the RNA pol II that coordinates mRNA synthesis, imprinting and stability in cooperation with RBPs.
Collapse
Affiliation(s)
- A I Garrido-Godino
- Departamento de Biología Experimental-Genética, Universidad de Jaén, Jaén, Spain
| | - I Gupta
- Department of Biochemical Engineering and Biotechnology, IIT Delhi, Hauz Khas, India
| | - F Gutiérrez-Santiago
- Departamento de Biología Experimental-Genética, Universidad de Jaén, Jaén, Spain
| | - A B Martínez-Padilla
- Departamento de Biología Experimental-Genética, Universidad de Jaén, Jaén, Spain
| | - A Alekseenko
- SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
| | - L M Steinmetz
- European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany.,Stanford Genome Technology Center, Stanford University, Palo Alto, CA, USA.,Department of Genetics, School of Medicine, Stanford University, Stanford, CA, USA
| | - J E Pérez-Ortín
- E.R.I. Biotecmed, Facultad de Biológicas, Universitat de València, Burjassot, Spain
| | - V Pelechano
- SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Sweden
| | - F Navarro
- Departamento de Biología Experimental-Genética, Universidad de Jaén, Jaén, Spain.,Centro de Estudios Avanzados en Aceite de Oliva y Olivar, Universidad de Jaén, Jaén, Spain
| |
Collapse
|
21
|
Fleifel H, Izadi M, Park S, Gupta I, Lee G, Kam SI. Shallow Subsurface Environmental Remediation by Using Tracer–Surfactant–Foam Processes: History-Matching and Performance Prediction. Transp Porous Media 2020. [DOI: 10.1007/s11242-020-01458-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Shemesh OA, Linghu C, Piatkevich KD, Goodwin D, Celiker OT, Gritton HJ, Romano MF, Gao R, Yu CCJ, Tseng HA, Bensussen S, Narayan S, Yang CT, Freifeld L, Siciliano CA, Gupta I, Wang J, Pak N, Yoon YG, Ullmann JFP, Guner-Ataman B, Noamany H, Sheinkopf ZR, Park WM, Asano S, Keating AE, Trimmer JS, Reimer J, Tolias AS, Bear MF, Tye KM, Han X, Ahrens MB, Boyden ES. Precision Calcium Imaging of Dense Neural Populations via a Cell-Body-Targeted Calcium Indicator. Neuron 2020; 107:470-486.e11. [PMID: 32592656 DOI: 10.1016/j.neuron.2020.05.029] [Citation(s) in RCA: 59] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2018] [Revised: 05/09/2019] [Accepted: 05/20/2020] [Indexed: 01/11/2023]
Abstract
Methods for one-photon fluorescent imaging of calcium dynamics can capture the activity of hundreds of neurons across large fields of view at a low equipment complexity and cost. In contrast to two-photon methods, however, one-photon methods suffer from higher levels of crosstalk from neuropil, resulting in a decreased signal-to-noise ratio and artifactual correlations of neural activity. We address this problem by engineering cell-body-targeted variants of the fluorescent calcium indicators GCaMP6f and GCaMP7f. We screened fusions of GCaMP to natural, as well as artificial, peptides and identified fusions that localized GCaMP to within 50 μm of the cell body of neurons in mice and larval zebrafish. One-photon imaging of soma-targeted GCaMP in dense neural circuits reported fewer artifactual spikes from neuropil, an increased signal-to-noise ratio, and decreased artifactual correlation across neurons. Thus, soma-targeting of fluorescent calcium indicators facilitates usage of simple, powerful, one-photon methods for imaging neural calcium dynamics.
Collapse
Affiliation(s)
- Or A Shemesh
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; Department of Biological Engineering, MIT, Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA; Department of Neurobiology and Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Changyang Linghu
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA; Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA, USA
| | - Kiryl D Piatkevich
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; Department of Biological Engineering, MIT, Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA; School of Life Sciences, Westlake University, Hangzhou, Zhejiang Province, China
| | - Daniel Goodwin
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA
| | - Orhan Tunc Celiker
- MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA; Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA, USA
| | - Howard J Gritton
- Boston University, Department of Biomedical Engineering, Boston, MA 02215, USA
| | - Michael F Romano
- Boston University, Department of Biomedical Engineering, Boston, MA 02215, USA
| | - Ruixuan Gao
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA
| | - Chih-Chieh Jay Yu
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; Department of Biological Engineering, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA
| | - Hua-An Tseng
- Boston University, Department of Biomedical Engineering, Boston, MA 02215, USA
| | - Seth Bensussen
- Boston University, Department of Biomedical Engineering, Boston, MA 02215, USA
| | - Sujatha Narayan
- Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA
| | - Chao-Tsung Yang
- Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA
| | - Limor Freifeld
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA; Faculty of Biomedical Engineering, Technion, Haifa, Israel
| | - Cody A Siciliano
- Vanderbilt Center for Addiction Research, Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA
| | - Ishan Gupta
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; Department of Biological Engineering, MIT, Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA
| | - Joyce Wang
- The Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA
| | - Nikita Pak
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA; Department of Mechanical Engineering, MIT, Cambridge, MA, USA
| | - Young-Gyu Yoon
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA; Department of Electrical Engineering and Computer Science, MIT, Cambridge, MA, USA; School of Electrical Engineering, KAIST Institute for Health Science and Technology, Daejeon, Republic of Korea
| | - Jeremy F P Ullmann
- Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital & Harvard Medical School, Boston, MA, USA
| | - Burcu Guner-Ataman
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA
| | - Habiba Noamany
- The Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA
| | - Zoe R Sheinkopf
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA
| | | | - Shoh Asano
- Internal Medicine Research Unit, Pfizer, Cambridge, MA, USA
| | - Amy E Keating
- Department of Biological Engineering, MIT, Cambridge, MA, USA; Department of Biology, MIT, Cambridge, MA, USA; Koch Institute, MIT, Cambridge, MA 02139, USA
| | - James S Trimmer
- Department of Physiology and Membrane Biology, University of California, Davis School of Medicine, Davis, CA, USA
| | - Jacob Reimer
- Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA; Center for Neuroscience and AI, Baylor College of Medicine, Houston, TX, USA
| | - Andreas S Tolias
- Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA; Center for Neuroscience and AI, Baylor College of Medicine, Houston, TX, USA; Department of Electrical and Computer Engineering, Rice University, Houston, TX, USA
| | - Mark F Bear
- The Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA
| | - Kay M Tye
- The Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, MIT, Cambridge, MA 02139, USA; Salk Institute for Biological Studies, La Jolla, CA 92037, USA
| | - Xue Han
- Boston University, Department of Biomedical Engineering, Boston, MA 02215, USA
| | - Misha B Ahrens
- Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA
| | - Edward S Boyden
- The MIT Media Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; Department of Biological Engineering, MIT, Cambridge, MA, USA; MIT Center for Neurobiological Engineering, MIT, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, MIT, Cambridge, MA, USA; MIT McGovern Institute for Brain Research, MIT, Cambridge, MA, USA; Koch Institute, MIT, Cambridge, MA 02139, USA.
| |
Collapse
|
23
|
Sarkar S, Singh A, Gupta I, Epelbaum O. CHALLENGES FACED DURING MATERNAL CARDIO-RESPIRATORY COLLAPSE: A CASE OF AMNIOTIC FLUID EMBOLISM. Chest 2020. [DOI: 10.1016/j.chest.2020.05.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
24
|
Gupta I, Freid B, Masarapu V, Machado P, Trabulsi E, Wallace K, Halpern E, Forsberg F. Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection. Urology 2019; 138:106-112. [PMID: 31899231 DOI: 10.1016/j.urology.2019.12.025] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2019] [Revised: 12/21/2019] [Accepted: 12/23/2019] [Indexed: 12/15/2022]
Abstract
OBJECTIVE To assess the prostate cancer (CaP) detection rates of contrast-enhanced, transrectal subharmonic ultrasound imaging (SHI). MATERIALS AND METHODS This IRB-approved study enrolled 55 subjects. The initial 5 subjects were studied for SHI optimization, while the remaining 50 were evaluated with contrast-enhanced sonography using continuous SHI, color, and power Doppler as well as conventional grayscale, continuous color, and power Doppler and SHI combined with maximum flash replenishment. A maximum of 6 directed biopsy cores were obtained from sites of greatest asymmetrical enhancement, followed by spatially distributed cores in a double sextant distribution. Subharmonic time-intensity parameters, including time to peak intensity, peak intensity, and estimated perfusion were also evaluated for each directed biopsy core. Receiver operating characteristic curve analysis and conditional logistic regression were employed to assess the benefit of each modality and the quantitative SHI parameters. RESULTS Cancer was detected in 22 of 50 subjects. Among subjects with clinically significant CaP (n = 11), targeted cores were more likely to be positive (odds ratio 1.39, P = .02). The majority of patients detected by SHI demonstrated significant CaP (5/8); SHI remained an independent marker of malignancy in a multivariate logistic regression model (P = .027). Receiver operating characteristic curve analysis of imaging findings compared to biopsy results yielded diagnostic accuracies ranging from 0.59 to 0.80 for all imaging modalities with the highest being for quantitative subharmonic perfusion estimates. CONCLUSION This first-in-humans study provides a preliminary estimate of the diagnostic accuracy of SHI for detection of clinically significant CaP (up to 80%).
Collapse
Affiliation(s)
- I Gupta
- Thomas Jefferson University, Philadelphia, PA
| | - B Freid
- Thomas Jefferson University, Philadelphia, PA
| | - V Masarapu
- Thomas Jefferson University, Philadelphia, PA
| | - P Machado
- Thomas Jefferson University, Philadelphia, PA
| | - E Trabulsi
- Thomas Jefferson University, Philadelphia, PA
| | | | - E Halpern
- Thomas Jefferson University, Philadelphia, PA
| | - F Forsberg
- Thomas Jefferson University, Philadelphia, PA.
| |
Collapse
|
25
|
Patil R, Levin S, Halery N, Gupta I, Rajkumar S. A SMARTPHONE-BASED EARLY ALERT SYSTEM FOR SCREENING OF COLIFORM CONTAMINATION IN DRINKING WATER. J microb biotech food sci 2019. [DOI: 10.15414/jmbfs.2019/20.9.3.539-547] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
We present a proof of concept for quick screening and alerting of coliform/E. coli contamination in water samples using a device attached to a smartphone. Current methods of coliform detection rely upon relatively expensive laboratory-based time consuming techniques which require trained manpower and take at least 24-48 hours. This waiting time prevents quick action and the consequences can be severe since the contaminated water may already have been consumed by then. Instead an unattended smartphone can continuously monitor the sample and send an alert as soon as contamination is detected. Smartphones, especially older or unused ones, fitted with a customized compact incubator and a sample holder, can be set to take photos of the sample (mixed with a selective growth medium) at regular intervals. An image analysis algorithm would analyze the photos and predict contamination as soon as it notices any increase in turbidity and/or change in color of the sample under observation due to bacterial growth. On detection of contamination, alerts can be immediately sent out to the concerned parties and intervention can be made without any potentially harmful delay. To test this concept we built a prototype for the detection of coliform/E. coli contamination in water samples. With the initial bacterial counts varying from 1-10 to >108 colony forming units (CFU) per 100 ml of water samples, all the results were produced within a turnaround time of 4 to 12 hours and found to be comparable with conventional microbiological methods which require 24-48 hours of incubation.
Collapse
|
26
|
Chew D, Constandinou T, Gupta I, Hann M, Porter R, Witherington J. Bioelectronic medicines: past, present and future. Highlights from The Society for Medicines Research Symposium. London, UK - October 1, 2019. DRUG FUTURE 2019. [DOI: 10.1358/dof.2019.44.11.3084328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
27
|
Gupta I, Young AMJ. Metabotropic glutamate receptor modulation of dopamine release in the nucleus accumbens shell is unaffected by phencyclidine pretreatment: In vitro assessment using fast-scan cyclic voltammetry rat brain slices. Brain Res 2018. [PMID: 29524437 DOI: 10.1016/j.brainres.2018.03.007] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The non-competitive glutamate antagonist, phencyclidine is used in rodents to model behavioural deficits see in schizophrenia. Importantly, these deficits endure long after the cessation of short-term chronic treatment (sub-chronic), indicating that the drug treatment causes long-term changes in the physiology and/or chemistry of the brain. There is evidence that this may occur through glutamatergic modulation of mesolimbic dopamine release, perhaps involving metabotropic glutamate receptors (mGluR). This study sought to investigate the effect of sub-chronic phencyclidine pretreatment on modulation of dopamine neurotransmission by metabotropic glutamate receptors 2 and 5 (mGluR2 and mGluR5) in the nucleus accumbens shell in vitro, with the hypothesis that phencyclidine pretreatment would disrupt the mGluR-mediated modulation of dopamine release. We showed that the orthosteric mGluR2 agonist LY379268 (0.1 µM, 1 µM and 10 µM) and mGluR5 positive allosteric modulator CDPPB (1 µM and 10 µM) both attenuated potassium-evoked dopamine release, underscoring their role in modulating dopamine neurotransmission in the nucleus accumbens. Sub-chronic PCP treatment, which caused cognitive deficits measured by performance in the novel object recognition task, modelling aspects of behavioral deficits seen in schizophrenia, induced neurobiological changes that enhanced dopamine release in the nucleus accumbens, but had no effect on mGluR2 or mGluR5 mediated changes in dopamine release. Therefore it is unlikely that schizophrenia-related behavioural changes seen after sub-chronic phencyclidine pre-treatment are mediated through mGluR modulation of dopamine release.
Collapse
Affiliation(s)
- Ishan Gupta
- Department of Neuroscience, Psychology and Behaviour, University of Leicester, Lancaster Road, Leicester LE1 9HN, UK
| | - Andrew M J Young
- Department of Neuroscience, Psychology and Behaviour, University of Leicester, Lancaster Road, Leicester LE1 9HN, UK.
| |
Collapse
|
28
|
Stein E, Fathi A, DiNardo C, Pollyea D, Swords R, Roboz G, Collins R, Sekeres M, Stone R, Attar E, Tosolini A, Xu Q, Amatangelo M, Gupta I, Knight R, de Botton S, Tallman M, Kantarjian H. Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS). Leuk Res 2017. [DOI: 10.1016/s0145-2126(17)30151-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
29
|
Abstract
A simple strategy for making nanoparticles by sonofragmentation of high-aspect-ratio 1D substrates is introduced. With common laboratory equipment, ultra-thin nanowires are fragmented into nanoparticles of size determined by the nanowire width, resulting within hours in monodisperse, crystalline nanoparticles of < 10 nm. This strategy is applicable to a diversity of semiconductor, oxide and metal nanowires.
Collapse
Affiliation(s)
- Ruixuan Gao
- Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139
| | - Ishan Gupta
- Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139
| | - Edward S Boyden
- Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139
| |
Collapse
|
30
|
Shailja S, Gupta I, Suri V. Inferior vena cava diameters in pregnant women for prediction of pregnancy-induced hypertension. Int J Gynaecol Obstet 2017; 84:164-5. [PMID: 14871520 DOI: 10.1016/s0020-7292(03)00157-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2002] [Revised: 03/28/2003] [Accepted: 04/09/2003] [Indexed: 11/18/2022]
Affiliation(s)
- S Shailja
- Department of Obstetrics and Gynaecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
| | | | | |
Collapse
|
31
|
Gupta I, Goyal A, Singh NK, Yadav HN, Sharma PL. Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart. Hum Exp Toxicol 2016; 36:867-875. [PMID: 27738197 DOI: 10.1177/0960327116673169] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
BACKGROUND Attenuated cardioprotective effect of ischemic preconditioning (IPC) by reduced nitric oxide (NO) is a hallmark during diabetes mellitus (DM). Recently, we reported that the formation of caveolin-endothelial nitric oxide synthase (eNOS) complex decreases the release of NO, which is responsible for attenuation of IPC-induced cardioprotection in DM rat heart. Heme oxygenase-1 (HO-1) facilitates release of NO by disrupting caveolin-eNOS complex. The activity of HO-1 is decreased during DM. This study was designed to investigate the role of hemin (HO-1 inducer) in attenuated cardioprotective effect of IPC in isolated diabetic rat heart. METHODS DM was induced in male Wistar rat by single dose of streptozotocin. Cardioprotective effect was assessed in terms of myocardial infarct size and release of lactate dehydrogenase and creatine kinase in coronary effluent. The release of NO was estimated indirectly by measuring the release of nitrite in coronary effluent. Perfusion of sodium nitrite, a precursor of NO, was used as a positive control. RESULT IPC-induced cardioprotection and increased release of nitrite were significantly attenuated in a diabetic rat as compared to a normal rat. Pretreatment with hemin and daidzein, a caveolin inhibitor, alone or in combination significantly restored the attenuated cardioprotection and increased the release of nitrite in diabetic rat heart. Zinc protoporphyrin, a HO-1 inhibitor, significantly abolished the observed cardioprotection and decreased the release of nitrite in hemin pretreated DM rat heart. CONCLUSION Thus, it is suggested that hemin restores the attenuated cardioprotective effect in diabetic rat heart by increasing the activity of HO-1 and subsequently release of NO.
Collapse
Affiliation(s)
- I Gupta
- 1 Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India
| | - A Goyal
- 2 Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
| | - N K Singh
- 2 Institute of Pharmaceutical Research, GLA University, Mathura, Uttar Pradesh, India
| | - H N Yadav
- 3 All India Institute of Medical Sciences (AIIMS), New Delhi, India
| | - P L Sharma
- 1 Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India
| |
Collapse
|
32
|
Carta D, Guttmann P, Regoutz A, Khiat A, Serb A, Gupta I, Mehonic A, Buckwell M, Hudziak S, Kenyon AJ, Prodromakis T. X-ray spectromicroscopy investigation of soft and hard breakdown in RRAM devices. Nanotechnology 2016; 27:345705. [PMID: 27420908 DOI: 10.1088/0957-4484/27/34/345705] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Resistive random access memory (RRAM) is considered an attractive candidate for next generation memory devices due to its competitive scalability, low-power operation and high switching speed. The technology however, still faces several challenges that overall prohibit its industrial translation, such as low yields, large switching variability and ultimately hard breakdown due to long-term operation or high-voltage biasing. The latter issue is of particular interest, because it ultimately leads to device failure. In this work, we have investigated the physicochemical changes that occur within RRAM devices as a consequence of soft and hard breakdown by combining full-field transmission x-ray microscopy with soft x-ray spectroscopic analysis performed on lamella samples. The high lateral resolution of this technique (down to 25 nm) allows the investigation of localized nanometric areas underneath permanent damage of the metal top electrode. Results show that devices after hard breakdown present discontinuity in the active layer, Pt inclusions and the formation of crystalline phases such as rutile, which indicates that the temperature increased locally up to 1000 K.
Collapse
Affiliation(s)
- D Carta
- Nano Group, Southampton Nanofabrication Centre, Department of Electronics and Computer Science, University of Southampton, Southampton SO17 1BJ, UK
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Abstract
Objective: To study the histological changes in varicosities after injection of 5% ethanolamine. Design: A prospective study in nine groups of six patients awaiting bilateral varicose vein surgery. Patients: Each patient had a below-knee incompetent perforating vein injected with either 0.5, 1.0 or 2.0 ml 5% ethanolamine. The contralateral varicosity received a similar volume of normal saline. Intervention: The patients wore elasticated stockings until admitted for operation at 2, 4 or 8 weeks after the injections. The injected varicosity was then dissected out. Main outcome measures: Each vein was reported on by a histologist who did not know which had received ethanolamine or saline. The histologist graded each vein according to the severity of change from 0 (no effect) to 5 (total obliteration of vein). Results: Ethanolamine at 0.5, 1.0 and 2.0 ml caused extensive histological damage to the varicosity. After 8 weeks most varicosities had been destroyed. Conclusion: Ethanolamine, unlike sodium tetradecyl sulphate, causes complete destruction of a varicosity. A dose of 0.5 ml is just as effective as 2.0 ml.
Collapse
Affiliation(s)
- J. G. Mosley
- Departments of Vascular Surgery and Pathology, Leigh Infirmary, Leigh, UK
| | - I. Gupta
- Departments of Vascular Surgery and Pathology, Leigh Infirmary, Leigh, UK
| |
Collapse
|
34
|
Rai M, Ingle A, Gaikwad S, Gupta I, Gade A, Silvério da Silva S. Nanotechnology based anti-infectives to fight microbial intrusions. J Appl Microbiol 2016; 120:527-42. [DOI: 10.1111/jam.13010] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2015] [Revised: 08/26/2015] [Accepted: 08/29/2015] [Indexed: 12/14/2022]
Affiliation(s)
- M. Rai
- Nanobiotechnology Laboratory; Department of Biotechnology; S.G.B. Amravati University; Amravati Maharashtra India
| | - A.P. Ingle
- Nanobiotechnology Laboratory; Department of Biotechnology; S.G.B. Amravati University; Amravati Maharashtra India
| | - S. Gaikwad
- Nanobiotechnology Laboratory; Department of Biotechnology; S.G.B. Amravati University; Amravati Maharashtra India
- Department of Biotechnology; Engineering School of Lorena; Estrada municipal do Campinho; University of Sao Paulo; Lorena SP Brazil
| | - I. Gupta
- Nanobiotechnology Laboratory; Department of Biotechnology; S.G.B. Amravati University; Amravati Maharashtra India
- Department of Biotechnology; Institute of Science; Aurangabad Maharashtra India
| | - A. Gade
- Nanobiotechnology Laboratory; Department of Biotechnology; S.G.B. Amravati University; Amravati Maharashtra India
| | - S. Silvério da Silva
- Department of Biotechnology; Engineering School of Lorena; Estrada municipal do Campinho; University of Sao Paulo; Lorena SP Brazil
| |
Collapse
|
35
|
Affiliation(s)
| | - Achal Sharma
- Department of Neurosurgery, Sawai Man Singh Medical College, Jaipur, Rajasthan, India
| | - R. Mittal
- Department of Neurosurgery, Sawai Man Singh Medical College, Jaipur, Rajasthan, India
| | - I. Gupta
- Department of Neurosurgery, Sawai Man Singh Medical College, Jaipur, Rajasthan, India
| | - Anand Sharma
- Department of Neurosurgery, Sawai Man Singh Medical College, Jaipur, Rajasthan, India
| |
Collapse
|
36
|
Gupta I, Ouhtit A, Fernando A, Abd Elmageed Z, Shanmuganathan S. CD146/Akt/NF-kappa-B/Latexin, a novel pathway suppressing breast tumor growth. Ann Oncol 2015; 26:iii31. [DOI: 10.1093/annonc/mdv121.05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/02/2023] Open
|
37
|
Gupta I, Ouhtit A, Riyami MA, Ajmi AA. P234 BRIP-1, a novel marker of breast tumor malignancy in the Omani population. Breast 2015. [DOI: 10.1016/s0960-9776(15)70266-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
38
|
Ouhtit A, Fernando A, Elmageed ZA, Gupta I, Shanmuganathan S. P233 CD146/Akt/NF-κB/latexin is a novel pathway involved in suppressing breast tumor growth. Breast 2015. [DOI: 10.1016/s0960-9776(15)70265-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
39
|
Price A, Sarween N, Gupta I, Baharani J. Meticillin-resistant Staphylococcus aureus and meticillin-susceptible Staphylococcus aureus screening in a cohort of haemodialysis patients: carriage, demographics and outcomes. J Hosp Infect 2015; 90:22-7. [PMID: 25676114 DOI: 10.1016/j.jhin.2015.01.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2014] [Accepted: 01/04/2015] [Indexed: 11/30/2022]
Abstract
BACKGROUND Patients on haemodialysis are vulnerable to colonization with Staphylococcus aureus due to frequent hospital contact, indwelling devices, and impaired immunity. Additionally colonization is associated with increased risk of infection. AIM To determine the prevalence of both meticillin-resistant S. aureus (MRSA) and meticillin-susceptible S. aureus (MSSA) carriage in our haemodialysis cohort and to identify any risk factors predisposing to carriage, recolonization, or persistent carriage following a decolonization programme. METHODS All haemodialysis patients screened for S. aureus carriage between June 2009 and May 2011 were retrospectively followed up for 18 months using hospital electronic records. Statistical analysis was performed using IBM SPSS version 19. FINDINGS Out of 578 patients screened, 288 patients (49%) had at least one positive swab (10% MRSA, 90% MSSA). Of these patients, 265 completed a course of decolonization therapy following which 36% successfully eradicated (eradicators) and 64% did not (non-eradicators). There was no statistically significant difference in patient demography, type of vascular access, 18-month patient mortality, or number of hospital admissions between the two groups. Those who failed to eradicate were more likely to have had an episode of S. aureus bacteraemia within the study period compared to those who successfully decolonized (P = 0.003). CONCLUSION Half of our haemodialysis cohort was colonized with S. aureus at any one time over an 18-month period. Following decolonization, one-third of patients remained successfully eradicated for 18 months. Non-eradicators have an increased risk of bacteraemia, which is associated with poor mortality. We would recommend routine screening and aggressive attempts to decolonize.
Collapse
Affiliation(s)
- A Price
- Department of Nephrology, Heart of England Foundation Trust, Birmingham, UK.
| | - N Sarween
- Department of Nephrology, Heart of England Foundation Trust, Birmingham, UK
| | - I Gupta
- Department of Microbiology, Birmingham Public Health Laboratory, Public Health England and Heart of England Foundation Trust, Birmingham, UK
| | - J Baharani
- Department of Nephrology, Heart of England Foundation Trust, Birmingham, UK
| |
Collapse
|
40
|
Gupta I, Shanmuganathan S, Ouhtit A. 370 Discovery of the genes that underpin the transition to malignant phenotype of breast tissues in a highly consanguineous region. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)70496-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
41
|
Ouhtit A, Gupta I, Shanmuganathan S, Al-Kindy I, Al-Riyami H. Molecular mechanisms underpinning the effectiveness of the combination of camel milk and urine in the clearance of breast cancer cells. PharmaNutrition 2014. [DOI: 10.1016/j.phanu.2013.11.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Ouhtit A, Gupta I, Fernando A, Gaur R, Shanmuganathan S, Al-Riyami H, Raj M. CD146 Suppresses Breast Tumor Invasion via its Novel Downstream Transcriptional Target Gene, TIMPV. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu070.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
43
|
Gupta I, Abdraboh M, Hollenbach A, Shanmuganathan S, Al-Riyami H, Raj M, Ouhtit A. The Interplay Between the Cell Adhesion Molecules CD44 and CD146 in Breast Cancer Metastasis. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu070.4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
44
|
Al-Riyami H, Gupta I, Madani S, Shanmuganathan S, Abdraboh ME, Al-Farsi Y, Raj M, Ouhtit A. TGF-β2, a Novel Target of CD44-Promoted Breast Cancer Invasion. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu070.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
45
|
Al-Riyami H, Madani S, Gupta I, Shanmuganathan S, Abdraboh ME, Al-Farsi Y, Raj MHG, Ouhtit A. Abstract P6-04-16: TGF-b2, a novel target of CD44-promoted breast cancer invasion. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p6-04-16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Hyaluronan (HA) mediates communication between cancer cells and the environment via interactions with the cell surface receptor CD44. We have previously shown that CD44-HA interaction in BC cells promotes adhesion to bone marrow endothelial cells. This suggests that HA/CD44 signalling may be correlated with breast cancer (BC) metastasis. The long-term objective of this study is to increase our understanding of the mechanisms by which CD44-HA interaction promotes BC metastasis, and further identify and validate CD44-downstream transcriptional targets for anti-metastatic therapy.
Pursuant to this goal, we have developed a tetracycline (tet)-regulated expression of CD44 gene in the BC cell line MCF-7 (B5 clone) and identified TGF-beta2 (Transforming Growth Factor beta-2; 3 fold induction) as a potential CD44s-downstream transcriptional target by microarray analysis. To further validate this finding, the same RNA samples, used for microarray analysis and their corresponding protein lysates collected from the BC cell line MCF-7-B5, were examined for CD44 expression in the presence of HA for 18, 24, and 48 hr post-tet withdrawal. Expression of TGF-beta 2 was examined using RT-PCR and western-Blot analyses.
Our results showed that TGF-beta2 mRNA levels were significantly elevated following the removal of tet at 18, 24, and 48 h post-HA stimulation compared to the parental cells. Furthermore, the TGF-beta2 precursor protein increased in a time-dependent pattern upon HA-stimulation and in the absence of tet. More interestingly, inhibition of CD44 gene by RNAi method decreased TGF-beta2 expression upon HA-stimulation and in the absence of tet.
Our data strongly support the hypothesis that TGF-beta2 is a potential target of HA/CD44- downstream-signaling mediating BC cell invasion. Ongoing investigation aims to elucidate the signal transduction pathways coupling CD44 to the regulation of TGF-beta2 expression, and further validate CD44/TGF-beta2 axes in breast tumor invasion and metastasis.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P6-04-16.
Collapse
Affiliation(s)
- H Al-Riyami
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat; LSU Health Sciences Center, New Orleans, LA
| | - S Madani
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat; LSU Health Sciences Center, New Orleans, LA
| | - I Gupta
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat; LSU Health Sciences Center, New Orleans, LA
| | - S Shanmuganathan
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat; LSU Health Sciences Center, New Orleans, LA
| | - ME Abdraboh
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat; LSU Health Sciences Center, New Orleans, LA
| | - Y Al-Farsi
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat; LSU Health Sciences Center, New Orleans, LA
| | - MHG Raj
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat; LSU Health Sciences Center, New Orleans, LA
| | - A Ouhtit
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat; LSU Health Sciences Center, New Orleans, LA
| |
Collapse
|
46
|
McCullough KP, Lok CE, Fluck RJ, Spergel LM, Andreucci VE, Fort J, Krishnan M, Fissell RB, Kawanishi H, Saran R, Port FK, Robinson BM, Pisoni RL, Shinzato T, Shionoya Y, Fukui H, Sasaki M, Miwa M, Toma S, Lin CC, Yang WC, Simone S, Loverre A, Cariello M, Divella C, Castellano G, Gesualdo L, Grandaliano G, Pertosa G, Mattei S, Pignatelli G, Corradini M, Stefani A, Bovino A, Iannuzzella F, Vaglio A, Manari A, Pasquali S, Chan JS, Wu TC, Roy-Chaudhury P, Shih CC, Chen JW, Ponce P, Scholz C, Goncalves P, Grassmann A, Canaud B, Marcelli D, Suzuki S, Shibata K, Kuji T, Kawata S, Koguchi N, Nishihara M, Satta H, Toya Y, Umemura S, Corbett R, Demicheli N, Iori F, Grechy L, Khiroya R, Ellis D, Crane J, Hamady M, Gedroyc W, Duncan N, Vincent P, Caro C, Sarween N, Price A, Powers S, Allen C, Holland M, Gupta I, Baharani J, Parisotto MT, Schoder V, Kaufmann P, Miriunis C, Grassmann A, Marcelli D, Moura A, Madureira J, Alija P, Fernandes J, Oliveira JG, Lopez M, Felgueiras M, Amado L, Sameiro-Faria M, Miranda V, Vieira M, Santos-Silva A, Costa E, David P, Capurro F, Brustia M, De Mauri A, Ruva C, Chiarinotti D, Gravellone L, De Leo M, Turkvatan A, Kirkpantur A, Mandiroglu S, Afsar B, Seloglu B, Alkis M, Erkula S, GURBUZ HG, Serin M, CALIK Y, Mandiroglu F, Balci M, Rikker C, Juhasz E, Tornoci L, Tovarosi S, Greguschik J, Rosivall L, Ibeas J, Valeriano J, Vallespin J, Fortuno J, Rodriguez-Jornet A, Cabre C, Merino J, Vinuesa X, Bolos M, Branera J, Mateos A, Jimeno V, Grau C, Criado E, Moya C, Ramirez J, Gimenez A, Garcia M, Kirmizis D, Kougioumtzidou O, Vakianis P, Bandera A, Veniero P, Brunori G, Dimitrijevic Z, Cvetkovic T, Paunovic K, Stojanovic M, Ljubenovic S, Mitic B, Djordjevic V, Aicha Henriette S, Farideh A, Daniela B, Zafer T, Francois C, Ibeas J, Vallespin J, Fortuno J, Merino J, Vinuesa X, Branera J, Mateos A, Jimeno V, Bolos M, Rodriguez-Jornet A, Gimenez A, Garcia M, Donati G, Scrivo A, Cianciolo G, La Manna G, Panicali L, Rucci P, Marchetti A, Giampalma E, Galaverni M, Golfieri R, Stefoni S, Skornyakov I, Kiselev N, Rozhdestvenskaya A, Stolyar A, Ancarani PPA, Devoto E, Dardano GGD, Coskun yavuz Y, Selcuk NY, Guney I, Altintepe L, Gerasimovska V, Gerasimovska-Kitanovska B, Persic V, Buturovic-Ponikvar J, Arnol M, Ponikvar R, Brustia M, De Mauri A, Conti N, Chiarinotti D, De Leo M, Capurro F, David P, Scrivano J, Pettorini L, Giuliani A, Punzo G, Mene P, Pirozzi N, Balci M, Turkvatan A, Mandiroglu S, Afsar B, Mandiroglu F, Kirkpantur A, Kocyigit I, Unal A, Guney A, Mavili E, Deniz K, Sipahioglu M, Eroglu E, Tokgoz B, Oymak O, Gunal A, Boubaker K, Kaaroud H, Kheder A, Ibeas J, Vidal M, Vallespin J, Amengual MJ, Merino J, Orellana R, Sanfeliu I, Rodriguez-Jornet A, Vinuesa X, Marquina D, Xirinachs M, Sanchez E, Moya C, Ramirez J, Rey M, Gimenez A, Garcia M, Strozecki P, Flisinski M, Kapala A, Manitius J, Gerasimovska V, Gerasimovska-Kitanovska BD, Sikole A, Weber E, Adrych D, Wolyniec W, Liberek T, Rutkowski B, Afsar B, Oguchi K, Nakahara T, Okamoto M, Iwabuchi H, Asano M, Rap O, Ruiz-Valverde M, Rodriguez-Murillo JA, Mallafre-Anduig JM, Zeid MM, Deghady AA, Elshair HS, Elkholy NA, Panagoutsos S, Devetzis V, Roumeliotis A, Kantartzi K, Mourvati E, Vargemezis V, Passadakis P, Kang SH, Jung SY, Lee SH, Cho KH, Park JW, Yoon KW, Do JY. Vascular access. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
47
|
Gupta I, Madani S, Abdraboh M, Al RH, Muzumdar S, AbdElmageed Z, Shanmuganathan S, Bhat S, Ramkumar A, Hakkim L, Ouhtit A. Abstract P4-06-16: TGF-β2, A Novel Target of CD44-Promoted Breast Cancer Invasion. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p4-06-16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Hyaluronan (HA) mediates communication between cancer cells and the environment via interactions with the cell surface receptor CD44. We have previously shown that CD44-HA interaction in BC cells promotes adhesion to bone marrow endothelial cells. This suggests that HA/CD44 signalling may be correlated with breast cancer (BC) metastasis. The long-term objective of this study is to increase our understanding of the mechanisms by which CD44-HA interaction promotes BC metastasis, and further identify and validate CD44-downstream transcriptional targets for anti-metastatic therapy.
Materials & Methods: Pursuant to this goal, we have developed a tetracycline (tet)-regulated expression of CD44 gene in the BC cell line MCF-7 (B5 clone) and identified TGF-β2 (Transforming Growth Factor beta-2; 3 fold induction) as a potential CD44s-downstream transcriptional target by microarray analysis. To further validate this finding, the same RNA samples, used for microarray analysis and their corresponding protein lysates collected from the BC cell line MCF-7-B5, were examined for CD44 expression in the presence of HA for 18, 24, and 48 hr post-tet withdrawal. Expression of TGF-β2 was examined using RT-PCR and western-Blot analyses.
Results: Our results showed that TGF-β2 mRNA levels were significantly elevated following the removal of tet at 18, 24, and 48 h post-HA stimulation compared to the parental cells. Furthermore, the TGF-β2 precursor protein increased in a time-dependent pattern upon HA-stimulation and in the absence of tet. More interestingly, inhibition of CD44 gene by RNAi method decreased TGF-β2 expression upon HA-stimulation and in the absence of tet.
Conclusion: Our data strongly support the hypothesis that TGF-β2 is a potential target of HA/CD44- downstream-signaling mediating BC cell invasion. Ongoing investigation aims to elucidate the signal transduction pathways coupling CD44 to the regulation of TGF-β2 expression, and further validate CD44/TGF-β2 axes in breast tumor invasion and metastasis.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P4-06-16.
Collapse
Affiliation(s)
- I Gupta
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - S Madani
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - M Abdraboh
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - Riyami H Al
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - S Muzumdar
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - Z AbdElmageed
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - S Shanmuganathan
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - S Bhat
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - A Ramkumar
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - L Hakkim
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| | - A Ouhtit
- College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Al Khuwd, Oman
| |
Collapse
|
48
|
Shanmuganathan S, AbdElmageed Z, Fernando A, Gaur R, Ramkumar A, Bhat S, Gupta I, Muzumdar S, Hakkim L, Ouhtit A. Abstract P4-06-14: CD146-suppresses breast tumor invasion via a novel transcription target TIMPv. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p4-06-14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
The function of the cell adhesion receptor CD146, a recently discovered marker of endothelial cells and a tumor promoter of melanoma and other cancers, is controversial in breast cancer (BC). However several lines of evidence supports its role as a tumor suppressor in BC. Further, the molecular mechanisms underpinning this suppression are unknown, neither has the ligand for CD146 been identified. Using a novel validated Enhanced Green Fluorescent Protein (EGFP)-inducible systems of CD146 expression both in vitro and in vivo, we provide here molecular and functional evidence of CD146 and its novel transcriptional target TIMPv (a variant of tissue inhibitor of metallo-proteinases) in underpinning the suppression of BC invasion.
Tetracycline (tet-on) CD146 system was developed in both MCF-7 and MDA-231 BC founder cell lines, and validated using time course RT-PCR and western blot analyses, and fluorescent microscopy. In functional experiments, induction of CD146 inhibited BC cell migration and invasion. TIMPv, the only endogenous protein inhibitor known for metallocarboxypeptidases, was identified by expression profiling as a novel transcriptional target of CD146-signaling, an association validated by quantitative PCR and immunoblotting experiments in a range of breast and melanoma cancer cells. However, siRNA inhibition of CD146 in the SKMel-28 melanoma cell line increased TIMPv expression, suggesting that while TIMPv is a positive transcriptional target of CD146 in BC cells, it is negatively regulated in melanoma cells. Furthermore, using invasion assay, the functional relevance of TIMPv to CD146-suppressed metastasis was demonstrated by selective suppression of TIMPv in CD146-expressing BC inducible cells using RNAi. More interestingly, induction of CD146 expression in vivo, using the tet-on CD146 expression system in BC Xenograft model resulted in suppression of breast tumor growth. Further, Clinical analysis of breast tissue samples by Immunohistochemistry showed that TIMPv expression patterns paralleled those of CD44s during breast tumor progression. Pharmacological and molecular approaches revealed that the activation of NFκB via Akt pathway couples CD146 to the transcription of TIMPv in BC cells.
Our study is the first report to provide a functional molecular link of a novel transcriptional target of CD146, TIMPv, to cancer via a unique axis that underpin CD146-suppressed BC progression; TIMPv is a potential target for guiding the development of novel therapeutic strategies for BC.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P4-06-14.
Collapse
Affiliation(s)
| | | | - A Fernando
- Sultan Qaboos University, Al-Khod, Seeb, Oman
| | - R Gaur
- Sultan Qaboos University, Al-Khod, Seeb, Oman
| | - A Ramkumar
- Sultan Qaboos University, Al-Khod, Seeb, Oman
| | - S Bhat
- Sultan Qaboos University, Al-Khod, Seeb, Oman
| | - I Gupta
- Sultan Qaboos University, Al-Khod, Seeb, Oman
| | - S Muzumdar
- Sultan Qaboos University, Al-Khod, Seeb, Oman
| | - L Hakkim
- Sultan Qaboos University, Al-Khod, Seeb, Oman
| | - A Ouhtit
- Sultan Qaboos University, Al-Khod, Seeb, Oman
| |
Collapse
|
49
|
Malla N, Kaul P, Sehgal R, Gupta I. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity. Indian J Med Microbiol 2011; 29:152-7. [DOI: 10.4103/0255-0857.81801] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
50
|
Malla N, Sehgal R, Kaul P, Gupta I. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity. Indian J Med Microbiol 2011. [DOI: 10.4103/0255-0857.90178] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|